A 10 year asthma programme in Finland: Major change for the better

Thorax

Volumn 61, Issue 8, 2006, Pages 663-670

  Haahtela, T ^a   Tuomisto, L E ^b   Pietinalho, A ^c   Klaukka, T ^d   Erhola, M ^e   Kaila, M ^f   Nieminen, M M ^g   Kontula, E ^c   Laitinen, L A ^h  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b SEINÄJOKI CENTRAL HOSPITAL   (Finland)

^c Filha   (Finland)

^d SOCIAL INSURANCE INSTITUTION   (Finland)

^e Municipal Joint Union for Public Health   (Finland)

^f PIRKANMAA HOSPITAL DISTRICT   (Finland)

^g TAMPERE UNIVERSITY HOSPITAL   (Finland)

^h HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; ANTIINFLAMMATORY AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID DERIVATIVE; STEROID;

ARTICLE; CIGARETTE SMOKING; COMPENSATION; COST BENEFIT ANALYSIS; DEMOGRAPHY; DOSE RESPONSE; DRUG INDUSTRY; EMERGENCY WARD; FINLAND; HEALTH CARE FACILITY; HEALTH PRACTITIONER; HOSPITAL ADMISSION; HOSPITAL CARE; HUMAN; INCIDENCE; INFLAMMATION; MAJOR CLINICAL STUDY; MEDICAL EDUCATION; MEDICAL SOCIETY; MEDICAL SPECIALIST; MORTALITY; OCCUPATIONAL ASTHMA; OUTPATIENT CARE; PENSION; PHYSICAL DISABILITY; PHYSICIAN; POST HOC ANALYSIS; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REHABILITATION CARE; SOCIAL INSURANCE;

ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; COMMUNICATION; COST OF ILLNESS; DISABLED PERSONS; EMERGENCY TREATMENT; FINLAND; HEALTH PROMOTION; HOSPITALIZATION; HUMANS; INCIDENCE; INSURANCE, DISABILITY; INTERPROFESSIONAL RELATIONS; NATIONAL HEALTH PROGRAMS; PHARMACEUTICAL SERVICES; PRIMARY HEALTH CARE; PROGRAM EVALUATION; SMOKING;

EID: 33747063315     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2005.055699     Document Type: Article

References (45)

1. NHLBI/WHO. Global strategy for asthma management and prevention. NHLBI/WHO Workshop Report, US National Heart, Lung and Blood Institute and the World Health Organisation, 1995.
2. National Institutes of Health (NIH). National asthma education and prevention program. Expert Panel Report 2: Guidelines for the diagnosis and management of asthma, NIH Publication No.97-4051. Bethesda, MD: National Institutes of Health, 1997.
3. North of England Asthma Guideline Development Group. North of England evidence based guidelines development project: summary version of evidence based guideline for the primary care management in adults. BMJ 1996;312:762-6.
4. National Institutes of Health (NIH). Global initiative for asthma. Global strategy for asthma management and prevention. Bethesda, MD: National Institutes of Health, 2004. Available at www.ginasthma.org.
5. Dahl R, Bjermer L. Nordic consensus report on asthma management. Respir Med 2000;94:299-327.
6. Boulet LP, Becker A, Berube D, et al. Canadian Asthma Consensus Report 1999. Canadian Asthma Consensus Group. Can Med Assoc J 1999;161(Suppl 11):S1-61.
7. Bousquet J, van Cauwenberge P, Khaltev N, et al. Allergic Rhinitis and its Impact on Asthma. ARIA Workshop Report. J Allergy Clin Immunol Suppl 2001;108(5):S147-334.
8. New Zealand Guidelines Group. The diagnosis and treatment of adult asthma. 2002. Available at http://www.nzgg.org.nz.
9. National Asthma Council Australia. Asthma management handbook, Updated 2002. National Asthma Council Australia. Available at www.nationalasthma.org.au.
10. British Thoracic Society, Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Thorax 2003;58(Suppl I):1-94.
11. International Primary Care Airways Group (IPAG). Chronic airways disease. A guide for primary care physicians. IPAG diagnosis and management handbook, MCR Vision, 2005.
12. Rabe KF, Vermeire PA, Soriano JB, et al. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000;16:802-7.
13. Rabe KF, Adachi M, Lai CKW, et al. Worldwide severity and control of asthma in children and adults: the global Asthma Insight and Reality surveys. J Allergy Clin Immunol 2004;114:40-7.
14. Cerveri I, Locatelli F, Zoia MC, et al. International variations in asthma treatment compliance: the results of the European Community Respiratory Health Survey (ECRHS). Eur Respir J 1999;14:288-94.
15. World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization, 2003:78.
16. Haahtela T, Laitinen LA. Asthma programme in Finland 1994-2004. Report of a Working Group. Qm Exp Allergy 1996;26:1-24.
17. Haahtela T, Klaukka T, Koskela K, et al. Asthma programme in Finland: a community problem needs community solutions. Thorax 2001;56:806-14.
18. Anon. Diagnosis and treatment of asthma, evidence based current care guideline (in Finnish). Duodecim 2000;116:2568-94 (updated 2006, in press).
19. Ikäheimo P, Tuuponen T, Hartikainen S, et al. Patients' low motivations makes problems in asthma management (in Finnish). Sosiaalivakuutus 2001;4:24-8.
20. Erhola M, Makinen R, Koskela K, et al. The Asthma Programme of Finland: an evaluation survey in primary health care. Int J Tuberc Lung Dis 2003;7:592-8.
21. Brander PE. Effect of regional asthma treatment chain on need for specialist care (in Finnish) Suom Lääkäril 2003;58:1803-10.
22. Peura S, Hirvonen A, Klaukka T. The first years of the Pharmacy Programme (in Finnish). Dosis 2004;20:147-51.
23. Klaukka T, Hirvonen A, Karhula K, et al. Good and bad news from asthma. Asthma barometer 2004 (in Finnish). Suom Lääkäril 2004;42:4002-4.
24. Kaila M, Pietinalho A, Vanto T, et al. The way childhood asthma is treated in Finland (in Finnish). Suom Lääkäril 2004;33:2937-9.
25. Ikäheimo P, Tuuponen T, Hartikainen S, et al. T. Achievements and shortcomings of Finnish asthma care. Scand J Public Health 2004;32:310-6.
26. Malmström K, Korhonen K, Kaila M, et al. Acute childhood asthma in Finland: a retrospective review of hospital admissions from 1976 to 1995. Pediatr Allergy Immunol 2000;11:236-40.
27. Valovirta E, Kocevar S, Kaila M, et al. Inpatient resource utilization in younger (2-5) and older (6-14) asthmatic children in Finland. Eur Respir J 2002;20:1-6.
28. Söynäjökangas O, Lampela P, Pietinalho A, et al. National COPD programme half a way: changes in hospital use (in Finnish). Suom iääkäril 2003;58:4729-32.
29. Karjalainen A, Kurppa K, Martikainen R, et al. Work is related to a substantial portion of adult-onset asthma incidence in the Finnish population. Am J Respir Crit Care Med 2001;164:565-8.
30. Peura S, Martikainen J, Klaukka T. Use and costs of asthma medication in 1980s (in Finnish, summary in English). Publication M: 72. Helsinki:Social Insurance Institution, 1990.
31. Hetakorpi S, Patja K, Prättälä R, et al. Health and health behaviour of Finnish adults (in Finnish). Publication B13/2004. Finnish National Institute of Health, 2004.
32. Kouluterveystutkimus. School health study (in Finnish). Available at http:// www.stakes.fi/kouluterveys/ktpaivat/index.html.
33. Helomo A. Impact and implementation of the Finnish Tobacco Act in workplaces, People and Work Reports 57. Helsinki: Finnish Institute of Occupational Health, 2003.
34. Piipari R, Jaakkola JJK, Jaakkola N, et al. Smoking and asthma in adults. Eur Respir J 2004;24:734-9.
35. Latvala J, von Hertzen L, Lindholm H, et al. Trends in prevalence of asthma and allergy in Finnish young men: nationwide study, 1966-2003. BMJ 2005;330:1186-7.
36. von Hertzen L, Haahtela T. Signs of reversing trends in prevalence of asthma. Allergy 2005;60:283-92.
37. Zöllner IK, Weiland SK, Piechotowski I, et al. No increase in the prevalence of asthma, allergies, and atopic sensitisation among children in Germany: 1992-2001. Thorax 2005;60:545-8.
38. Grimshaw JM, Russell IT. Achieving health gain through clinical guidelines. II. Ensuring guidelines change medical practice. Qual Health Care 1995;3:45-52.
39. Laitinen LA, Heino M, Laitinen A, et al. Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis 1985;131:599-606.
40. 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide in newly detected asthma. N Engl J Med 1991;325:388-92.
41. Haahtela T, Järvinen M, Kava T, et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 1994;331:700-5.
42. Lahdensuo A, Haahtela T, Herrala J, et al. Randomised comparison of self management and traditional treatment of asthma over one year. BMJ 1996;312:748-52.
43. Boushey HA, Sorkness CA, King TS, et al. Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med 2005;352:1519-28.
44. Partridge MR, Fabbri LM, Chung KF. Delivering effective asthma care - how do we implement asthma guidelines? Eur Respir J 2000;15:235-7.
45. Finnish Association for General Practice. Guidelines for smoking, nicotine dependency and interventions for cessation (in Finnish), 2003. Available at http://www.kaypahoito.fi/pls/kh/kaypahoito?suositus = hoi50016.